Chloroquine Market

Global Chloroquine Market Size, Share & Trends Analysis Report, by type (Injectables, Capsules, Tablets), by Application (Arthrophlogosis, Malaria, Other), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2024270 | Category : Pharmaceuticals | Delivery Format: /

The Global Chloroquine Market is estimated to grow at a moderate CAGR during the forecast period. Malaria is prevented and treated with chloroquine. It's also used to treat protozoa-related liver infections (extraintestinal amebiasis). In some hospitalised patients, chloroquine can be used to treat coronavirus (COVID-19). Antimalarials are a class of drugs that include chloroquine. It works by preventing or treating malaria, which is a red blood cell infection spread by mosquito bites. This drug, on the other hand, is not used to treat severe or complicated malaria or to prevent malaria in places or regions where chloroquine is known to be ineffective.

This medicine is also prescribed for the treatment of discoid lupus erythematosus, foundational lupus erythematosus, rheumatoid arthritis, and other immune system disorders. Chloroquine is also used to treat a variety of parasitic infections. The rising frequency of COVID-19 cases, as well as the growing prevention and treatment of malaria, rheumatoid arthritis, and other autoimmune disorders, are driving market expansion. Furthermore, as a result of the COVID-19 pandemic, chloroquine export and import across regions has grown, thus driving market expansion.

Some several restrictions and limitations will limit the market's expansion. Factors such as a lack of Chloroquine supply are potential limitations to the global Hydroxychloroquine And Chloroquine Market's overall growth. Nonetheless, ongoing technological advancements and unexplored potential in developing countries present great potential growth.

For Instance, on March 28, 2020, the FDA approved an Emergency Use Authorization (EUA) allowing chloroquine to be distributed to adults and adolescents weighing at least 110 pounds (50 kg) who are hospitalised with COVID-19 however are unable to participate in a clinical investigation. Chloroquine should only be used to treat COVID-19 under the supervision of a doctor in a clinical study, according to the FDA and the National Institutes of Health (NIH).

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segments Covered

o By Type

o By Application

  • Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

  • Competitive Landscape: Abcam Plc, ADVANZ PHARMA Corp., Bayer AG, Cadila Healthcare Ltd., Ipca Laboratories Ltd. among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Chloroquine Market by Segments

By Product Type

  •  Injectables
  • Capsules
  • Tablets

By Application

  • Arthrophlogosis
  • Malaria
  •  Others

Global Chloroquine Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT